Previous 10 | Next 10 |
home / stock / rvvtf / rvvtf news
TORONTO, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” and the “Company”) (CSE: RVV), a cannabis life sciences company focused on the research, development, and commercialization of novel cannabinoid-based products, is pleased to provide an...
The board of Revive Therapeutics ( OTCQB:RVVTF ) has appointed Michael Frank as CEO and has elected him Chairman. He joins the firm from Mifran Consulting where he was President. More news on: Revive Therapeutics Ltd., Healthcare stocks news, Read more ...
TORONTO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive" and the “Company") (CSE: RW), a cannabis life sciences company focused on the research, development, and commercialization of novel cannabinoid-based products, is pleased to announce that all the res...
Revive Therapeutics ( OTCQB:RVVTF ): Q1 Net loss of C$0.31M. More news on: Revive Therapeutics Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
TORONTO, Nov. 27, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” and the “Company”) (CSE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development, and commercialization of novel cannabinoid-based products, today announc...
Thinly traded nano cap Revive Therapeutics Ltd. ( OTCQB:RVVTF -25.7% ) is down on more than a 9x surge in volume, albeit on turnover of only 46K shares, following its announced joint venture (JV) with Herman Holdings Ltd. aimed at selling cannabis derivative products in the Canadian recr...
TORONTO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development, and commercialization of novel cannabinoid-based products, is pleased to announce that it has entered...
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. TORONTO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“ Revive ” or the “ Company ”...
TORONTO, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive") (CSE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development, and commercialization of novel cannabinoid-based products, today announced its results for the fiscal year ended June ...
TORONTO, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive") (CSE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development, and commercialization of novel cannabinoid-based products, is pleased to announce that on October 15, 2019 it has sign...
News, Short Squeeze, Breakout and More Instantly...
Revive Therapeutics Ltd. Company Name:
RVVTF Stock Symbol:
OTCMKTS Market:
TORONTO, April 23, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases...
TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious disease...
TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, a...